glp-1 agonists how do they work and Anesthesia: Considerations and Cautions for CRNAs The GLP-1 revolution: What UAB

Although dedicated trials of GLP-1RAs in AITD are lacking, preliminary reports suggest potential impacton thyroid volume, thyroid function, and autoimmune activity

In 2025 we saw label expansions for semaglutide and tirzepatide, underscoring a trend toward whole-body health

Indias pharma industry is strong

Introduction Our study has two objectives: (1) to evaluate the incidence and severity of food retention observed during esophagogastroduodenoscopies (EGDs) in patients with and without history of glucagon-like peptide-1 receptor agonist (GLP-1 RA) use and (2) to create a grading scale to standardize the language regarding food retention

however, GLP-1 receptor agonists were associated with a higher risk of discontinuation of endoscopy, possibly owing to a higher risk of retained gastric content